Eli Lilly said its new weight-loss pill had cleared a late-stage clinical trial, a promising sign as the company continues to ...

A doctor has shared some of the common reasons people taking weight loss jabs may notice hair loss, including those most likely to experience the side effect and how to combat it ...

Despite the current downward trend, long-term investors may stay invested in NVO stock due to strong demand for its GLP-1 ...

Viking's Q1 earnings show no revenue, increased R&D spending, and a substantial cash reserve, positioning it well for future ...

A DAD once nicknamed “Fat Pal” by his friends has dropped five stone in five months after using Mounjaro. Sean Burns, 32, from Glasgow, said he has “struggled with excess weight” his whole life ...

But recent weak U.S. prescription data is leading some investors and analysts to question whether that stellar run, which ...

Non-surgical weight loss treatments are becoming more accessible, effective, and more in tune with your body's natural ...

A U.S. study of over 500 youth aged 14–24 found high awareness but widespread hesitation about using semaglutide for weight ...

But nearly two years after the FDA approved the use of GLP-1 drugs in kids, some are questioning if these drugs are safe for ...

An estimated 24,499 people visited the ED for adverse events related to semaglutide in the 2 years after its approval for ...

A WOMAN who weighed 12st 10lbs and was a size 16 decided to try the weight loss jab after struggling to stick to diets, but things weren’t as perfect as she’d hoped. Kathleen Smith, ...

I thought you could help with a stubborn problem. I am a healthy and active 78-year-old woman who, I admit, likes to look ...